Search

Displaying results 1031 - 1040 of 10000 in total
  1. Drug

    MAHDL01

    go.drugbank.com/drugs/DB06270
    Experimental

    MAHDL01 is a pharmaceutical combination of whole plants, which is used to increase the HDL/LDL ratio that improves overall cardiovascular health.

  2. Drug

    Maxacalcitol

    go.drugbank.com/drugs/DB06272
    Investigational

    Categories: Vitamin D and Analogues, Compounds used in a research, industrial, or household setting
  3. Drug

    Alvimopan

    go.drugbank.com/drugs/DB06274
    ApprovedInvestigational

    Alvimopan is a peripherally acting μ opioid antagonist. It is used to avoid postoperative ileus following small or large bowel resection and accelerates the gastrointestinal recovery period.

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Dapagliflozin

    go.drugbank.com/drugs/DB06292
    ApprovedInvestigational

    Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, and it was the first SLGT2 inhibitor to be approved. indicated for managing diabetes mellitus type 2. … [A261601] Dapagliflozin was originally approved by the FDA on Jan 08, 2014, to improve glycemic control in adults with type 2 diabetes in conjunction with diet and exercise.

    Synonyms: (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triolMixtures: XIGLIF-M, PLEMTUM-M
  5. Drug

    Glesatinib

    go.drugbank.com/drugs/DB06302
    Investigational

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    BIIB015

    go.drugbank.com/drugs/DB06304
    Investigational

    BIIB015 is a humanized, IgG1 [immunoglobulin G 1], DM4-Conjugated, anti-cripto, monoclonal antibody. It has been investigated for the treatment of subjects with relapsed or refractory solid tumours.

  7. Drug

    Onalespib

    go.drugbank.com/drugs/DB06306
    Investigational

    Categories: Heterocyclic Compounds, 2-Ring
  8. Drug

    Motavizumab

    go.drugbank.com/drugs/DB06310
    Investigational

  9. Drug

    BNC105

    go.drugbank.com/drugs/DB06313
    Investigational

    Categories: Heterocyclic Compounds, 2-Ring
  10. Drug

    SGX-523

    go.drugbank.com/drugs/DB06314
    Investigational

    A MET receptor tyrosine kinase inhibitor.

    Synonyms: 6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinolineCategories: Heterocyclic Compounds, 1-Ring